New drug avexitide aims to stop severe sugar crashes after gastric bypass
Disease control
Ongoing
This study tests a drug called avexitide in 75 adults who have dangerous low blood sugar episodes after gastric bypass surgery. Participants receive either the drug or a placebo for 16 weeks to see if it reduces severe sugar crashes. The goal is to control the condition, not cure…
Phase: PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC